Dr Margaret Ross - Psilocybin Assisted Therapy at the End of Life: Notes from the edge

Поділитися
Вставка
  • Опубліковано 16 лип 2024
  • Please subscribe, like and comment on our videos to show support for EGA, the free way to say thanks for our special charity 😊🍄🌵
    We also invite you to visit our website with many more important resources, upcoming event and you can also join our monthly ethnobotanical newsletter and much more - www.entheogenesis.org/
    Dr Margaret Ross - Psilocybin Assisted Therapy at the End of Life: Notes from the Edge
    “I just feel so much happier. I know I’m dying but I’m not scared. It was beautiful. I can’t put it into words… It’s given me so much peace.” ~60 year old with metastatic prostate cancer and psilocybin-assisted therapy patient.
    The lovely Dr Margaret Ross shares her experiences conducting Australia’s first ever psychedelic clinical trial. Forty people with advanced-life threatening illness and depression and/or anxiety were given two psilocybin dosage sessions, six weeks apart.
    Dr Ross takes our hand and gently guides us through this profound, blissful and terrifying terrain; psychedelics at the end of life.
    00:00:00 Intro
    00:03:06 We need better psychedelic education
    00:07:15 Psychedelics aren’t right for everyone
    00:16:57 Psychedelic rituals
    00:22:56 Psychedelic integration and intention
    00:29:55 Eros and death
    00:32:22 Symbolism and non-verbal therapy
    00:34:40 Transcendent, profound, troubling, blissful and terrifying
    00:38:53 Music in psychedelic therapy
    00:42:09 Therapy playlist and experiences of people with terminally illness
    00:47:28 After the psychedelic experience
    00:48:32 The future of psychedelics
    00:51:05 Q&A
    Bio Dr Margaret Ross
    Dr Margaret Ross is a consultant clinical psychologist and the clinical lead in Australia’s first ever psychedelic clinical trial. The trial will be based at St Vincent’s Hospital in Melbourne and will investigate the ability of psilocybin-assisted therapy to alleviate anxiety and depression in terminally ill patients.
    The St Vincent’s clinical trial will see palliative care patients given one to two doses of psilocybin and psychotherapy in a treatment protocol shown in overseas trials to produce rapid and dramatic improvements in depression and anxiety, and provide an altered outlook on their situation approaching death. Alongside psychotherapy and guidance, the psychedelic medicines are hoped to give terminally ill patients a new perspective on their lives, and to reduce the fear and depression which can often take over their final months.
    Margaret will talk about the study's progress, its history, aims, and practical workings, whilst addressing the rationale for how psilocybin works to alleviate anxiety and depression.
    Further reading
    www.svhm.org.au/newsroom/news...
    www.prism.org.au
    www.abc.net.au/news/2023-05-2...
    -----
    About PRISM
    Building Australia's psychedelic research network
    Current and future Australian research in this space will offer a crucial pathway for the provision of psychedelic-assisted therapy and to develop our understanding of consciousness itself. Notably, none of the current research into psychedelic-assisted treatments for mental illness in Australia is receiving government funding. With your support, our research paves the way for establishing evidence-informed psychedelic-assisted treatments
    www.prism.org.au
    -----
    About EGA
    Entheogenesis Australis is a charitable educational organisation established in 2004. We provide opportunities for critical thinking and knowledge sharing on ethnobotanical plants, fungi, nature, and sustainability. Through our conferences and workshops, we aim to celebrate the culture, art, politics and community around medicine plants in the hope to better wellbeing for humankind and the planet.
    To find out more about what we do, head over to our organisational website, www.entheogenesis.org
    Catch us in person at our conference, www.gardenstates.org

КОМЕНТАРІ • 3